Literature DB >> 8963720

Plasma fibrinogen inhibits platelets adhesion in flowing blood to immobilized fibrinogen.

S C Endenburg1, L Lindeboom-Blokzijl, J J Zwaginga, J J Sixma, P G de Groot.   

Abstract

The influence of variations in plasma fibrinogen concentration on platelet adhesion to immobilized fibrinogen was investigated in a parallel-plate perfusion chamber. At a shear rate of 1600 s-1 platelet adhesion decreased when increasing concentrations of purified fibrinogen were added to the plasma (IC50 = 1.5 +/- 0.2 g/L fibrinogen, n = 24). Washed platelets reconstituted in a human albumin solution with red blood cells were more sensitive for soluble fibrinogen (IC50 = 0.4 +/- 0.1 g/L, n = 5, P < .05). When platelet activation during circulation of the blood was minimized by using a single-passage perfusion system, an IC50 of 2.0 +/- 0.2 g/L was found (n = 9). To exclude the possibility that the inhibition of fibrinogen was caused by irreversible changes in the fibrinogen molecule during the purification procedure, normal plasma was mixed in different ratios with plasma from a patient with congenital afibrinogenemia. Under these conditions, the plasma fibrinogen IC50 was 1.5 +/- 1.1 g/L. Absence of endogenous fibrinogen in the platelets of the patient resulted in an IC50 of 1.2 +/- 0.5 g/L for plasma fibrinogen. These results demonstrate that increased plasma fibrinogen concentrations inhibit platelet adhesion to fibrinogen under flow.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8963720     DOI: 10.1161/01.atv.16.5.633

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  9 in total

1.  Fibrinogen counteracts the antiadhesive effect of fibrin-bound plasminogen by preventing its activation by adherent U937 monocytic cells.

Authors:  V K Lishko; I S Yermolenko; H Owaynat; T P Ugarova
Journal:  J Thromb Haemost       Date:  2012-06       Impact factor: 5.824

2.  Efficiency of platelet adhesion to fibrinogen depends on both cell activation and flow.

Authors:  A Bonnefoy; Q Liu; C Legrand; M M Frojmovic
Journal:  Biophys J       Date:  2000-06       Impact factor: 4.033

Review 3.  Thrombosis in Inherited Fibrinogen Disorders.

Authors:  Wolfgang Korte; Man-Chiu Poon; Alfonso Iorio; Michael Makris
Journal:  Transfus Med Hemother       Date:  2017-03-14       Impact factor: 3.747

4.  The assembly of nonadhesive fibrinogen matrices depends on the αC regions of the fibrinogen molecule.

Authors:  Ivan S Yermolenko; Oleg V Gorkun; Alexander Fuhrmann; Nataly P Podolnikova; Valeryi K Lishko; Stanislav P Oshkadyerov; Susan T Lord; Robert Ros; Tatiana P Ugarova
Journal:  J Biol Chem       Date:  2012-10-18       Impact factor: 5.157

5.  Fibrinogen matrix deposited on the surface of biomaterials acts as a natural anti-adhesive coating.

Authors:  Roman Safiullin; Wayne Christenson; Hadil Owaynat; Ivan S Yermolenko; Marsil K Kadirov; Robert Ros; Tatiana P Ugarova
Journal:  Biomaterials       Date:  2015-07-14       Impact factor: 12.479

6.  Plasminogen on the surfaces of fibrin clots prevents adhesion of leukocytes and platelets.

Authors:  V K Lishko; I S Yermolenko; T P Ugarova
Journal:  J Thromb Haemost       Date:  2009-01-22       Impact factor: 5.824

7.  Identification of platelet function defects by multi-parameter assessment of thrombus formation.

Authors:  Susanne M de Witt; Frauke Swieringa; Rachel Cavill; Moniek M E Lamers; Roger van Kruchten; Tom Mastenbroek; Constance Baaten; Susan Coort; Nicholas Pugh; Ansgar Schulz; Inge Scharrer; Kerstin Jurk; Barbara Zieger; Kenneth J Clemetson; Richard W Farndale; Johan W M Heemskerk; Judith M E M Cosemans
Journal:  Nat Commun       Date:  2014-07-16       Impact factor: 14.919

8.  Venous Thrombosis and Thrombocyte Activity in Zebrafish Models of Quantitative and Qualitative Fibrinogen Disorders.

Authors:  Richard J Fish; Cristina Freire; Corinne Di Sanza; Marguerite Neerman-Arbez
Journal:  Int J Mol Sci       Date:  2021-01-11       Impact factor: 5.923

9.  Fibrinogen concentrate for treatment of bleeding and surgical prophylaxis in congenital fibrinogen deficiency patients.

Authors:  Toshko Lissitchkov; Bella Madan; Claudia Djambas Khayat; Nadezhda Zozulya; Cecil Ross; Mehran Karimi; Kaan Kavakli; Guillermo R De Angulo; Abdulkareem Almomen; Kannan Subramanian; Fulton D'Souza; Auro Viswabandya; Hamid Hoorfar; Bruce A Schwartz; Cristina Solomon; Sigurd Knaub; Flora Peyvandi
Journal:  J Thromb Haemost       Date:  2020-01-21       Impact factor: 5.824

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.